Overview
- 43 inspections across 40 sites are on record.
- 49 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-13.
At a glance
Inspections
43
Sites
40
Observations
49
Career since
Jan 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | 13 May 2026 | Human Drugs | |
| Pharmaneek Inc | 8 Apr 2026 | Human Drugs | On file |
| Curexa - East, LLC dba Curexa | 5 Mar 2026 | Human Drugs | |
| Neeyaan LLC | 27 Jan 2026 | Human Drugs | On file |
| Menasha Packaging Company, LLC | 6 Nov 2025 | Human Drugs | On file |
Sites inspected
Hikma Pharmaceuticals USA Inc.Cherry Hill, United States1 insp.
Pharmaneek IncIndianapolis, United States1 insp.
Curexa - East, LLC dba CurexaEgg Harbor Township, United States1 insp.
Neeyaan LLCCranbury, United States1 insp.
Menasha Packaging Company, LLCLititz, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Annet R Rajan7 shared
Ko U Min4 shared
Michael O Idowu3 shared
Helen Verdel3 shared
Young K Chou2 shared
Mindy M Chou2 shared
Stephenie M Ortiz2 shared
Daniel J Min2 shared
David A Oluwo2 shared
Charlotte P Chang1 shared
Full investigator report
Get the verbatim findings behind Janet A Rajan's 49 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site